Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease Alone

Inclusion Criteria: * Subjects with worsening chronic heart failure requiring emergency presentation to hospital and treatment with intravenous (IV) diuretics at hospital * Subjects with either type 2 DM or moderate CKD Exclusion Criteria: * Acute de-novo heart failure or acute inflammatory heart disease, e.g. acute myocarditis * Acute coronary syndrome (ACS) (elevated cardiac troponins which are not caused by an ACS are not an exclusion criterion) in the last 30 days prior to the screening visit * Cardiogenic shock * Valvular heart disease requiring surgical intervention during the course of the study * Subjects with left ventricular assistance device or waiting for heart transplantation * Stroke or transient ischemic cerebral attack in the last 3 months prior to the screening visit * Addison's disease